Clincosm LogoSign in Get a demo

Management of Diabetes Mellitus Patients With Retinopathy

Sponsor
AstraZeneca (Industry)
Overall Status
Completed
CT.gov ID
NCT00828425
Collaborator
(none)
2,500
Enrollment
62
Locations
8
Duration (Months)
40.3
Patients Per Site
5.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Aim of this NIS is to retrospectively document the management of diabetic patients with retinopathy in a naturalistic setting in Switzerland. Following elements are going to be analyzed:

  • which medication are used to keep blood pressure under control?

  • which medication are used for metabolic control?

  • the average control level of metabolism and blood pressure is compliant with the international guidelines?

  • laser photocoagulation plays a role in the control of metabolism and blood pressure?

  • there are differences in the control of metabolism and blood pressure between patients with DM I or DM II?

  • there is an influence of renal failure on the choose of medication?

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    2500 participants
    Time Perspective:
    Retrospective
    Official Title:
    Management of Diabetes Mellitus Patients With Retinopathy
    Study Start Date :
    Dec 1, 2008
    Actual Study Completion Date :
    Aug 1, 2009

    Arms and Interventions

    Arm Intervention/Treatment
    1

    Diabetic patients with retinopathy

    Outcome Measures

    Primary Outcome Measures

    1. Blood lipids, glycemia, HbA1C, blood creatinine, proteinuria, body weight [every 3 months]

    2. evolution of diabetic retinopathy [every 3 months]

    Secondary Outcome Measures

    1. concomitant medication [every 3 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Diabetic patients

    • Diabetic retinopathy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Research Site Dattwil AG Switzerland
    2 Research Site Hausen b. Brugg AG Switzerland
    3 Research Site Lenzburg AG Switzerland
    4 Research Site Lupfig AG Switzerland
    5 Research Site Muri AG AG Switzerland
    6 Research Site Rheinfelden AG Switzerland
    7 Research Site Schinznach Dorf AG Switzerland
    8 Research Site Spreitenbach AG Switzerland
    9 Research Site Bern BE Switzerland
    10 Research Site Moutier BE Switzerland
    11 Research Site Unterseen BE Switzerland
    12 Research Site Diegten BL Switzerland
    13 Research Site Laufen BL Switzerland
    14 Research Site Basel BS Switzerland
    15 Research Site Estavayer-le-Lac FR Switzerland
    16 Research Site Fribourg FR Switzerland
    17 Research Site Collonge-Bellerive GE Switzerland
    18 Research Site Geneve GE Switzerland
    19 Research Site Le Grand-Saconnex GE Switzerland
    20 Research Site Les Acacias GE Switzerland
    21 Research Site Versoix GE Switzerland
    22 Research Site Chur GR Switzerland
    23 Research Site Ilanz GR Switzerland
    24 Research Site Samedan GR Switzerland
    25 Research Site Alle JU Switzerland
    26 Research Site Luzern LU Switzerland
    27 Research Site Rothenburg LU Switzerland
    28 Research Site Le Locle NE Switzerland
    29 Research Site Kerns OW Switzerland
    30 Research Site Oberuzwil SG Switzerland
    31 Research Site Rorschach SG Switzerland
    32 Research Site St. Gallen SG Switzerland
    33 Research Site Wangs SG Switzerland
    34 Research Site Schaffhausen SH Switzerland
    35 Research Site Kussnacht am Rigi SZ Switzerland
    36 Research Site Tuggen SZ Switzerland
    37 Research Site Kreuzlingen TG Switzerland
    38 Research Site Ascona TI Switzerland
    39 Research Site Locarno TI Switzerland
    40 Research Site Lugano TI Switzerland
    41 Research Site Viganello TI Switzerland
    42 Research Site Aigle VD Switzerland
    43 Research Site Bassins VD Switzerland
    44 Research Site Bex VD Switzerland
    45 Research Site Chateau-d'Oex VD Switzerland
    46 Research Site Clarens VD Switzerland
    47 Research Site Eysins VD Switzerland
    48 Research Site Lausanne VD Switzerland
    49 Research Site Nyon VD Switzerland
    50 Research Site Prilly VD Switzerland
    51 Research Site Renens VD VD Switzerland
    52 Research Site Salavaux VD Switzerland
    53 Research Site St-Legier VD Switzerland
    54 Research Site Vevey VD Switzerland
    55 Research Site Ardon VS Switzerland
    56 Research Site Evionnaz VS Switzerland
    57 Research Site Saviese VS Switzerland
    58 Research Site Sierre VS Switzerland
    59 Research Site Sion VS Switzerland
    60 Research Site Bassersdorf ZH Switzerland
    61 Research Site Egg b. Zurich ZH Switzerland
    62 Research Site Winterthur ZH Switzerland

    Sponsors and Collaborators

    • AstraZeneca

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00828425
    Other Study ID Numbers:
    • NIS-CCH-DUM-2008/1
    First Posted:
    Jan 26, 2009
    Last Update Posted:
    Aug 18, 2010
    Last Verified:
    Aug 1, 2010
    Keywords provided by , ,
    Diabetes Mellitus
    retinopathy
    Management of diabetic patients with retinopathy
    Additional relevant MeSH terms:
    Retinal Diseases
    Diabetes Mellitus

    Study Results

    No Results Posted as of Aug 18, 2010